Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Rotary Capsule Filler Reduces Product Loss

February 18, 2015

MG America's TEKNA Capsule Filler has advanced controls to reduce powder loss and maintain optimal performance.

First Hospira Biosimilar mAb Approved in West Europe

February 17, 2015

Hospira’s Inflectra (infliximab), a biosimilar for Remicade, is approved by the European Commission.

New Financial Strategies Needed to Support Biomedical Innovation

February 17, 2015

The ongoing battle over drug reimbursement and pricing has raised questions about whether the pharmaceutical industry can continue to rely on high United States revenues to fund biopharmaceutical R&D.

CDER and Biotech Quality Assessment

February 11, 2015

The Center for Drug Evaluation and Research seeks a more flexible system for assessing biotech product quality.

Pfenex Announces Partnership with Hospira to Develop Lucentis Biosimilar

February 11, 2015

Pfenex announced that it entered into an agreement to partner with Hospira on the development and commercialization of PF582, a biosimilar candidate to Lucentis.

Amgen Announces Humira Biosimilar Clinical Studies Success

February 06, 2015

Amgen announced that it met primary and secondary endpoints in its biosimilar evaluation of adalimumab for the treatment of rheumatoid arthritis, when compared to Humira.

First Inhalable Insulin Comes to the US

February 04, 2015

Sanofi launched a rapidly absorbed, short-acting inhalable insulin in the US to help control type 1 and type 2 diabetes.

Mylan Partners with Theravance to Develop an Investigational Treatment for COPD

February 03, 2015

Mylan announced a partnership with Theravance Biopharma to develop and commercialize TD-4208, a novel investigational COPD treatment.

Obama Seeks Drug Pricing Authority, Shortened Data Exclusivity Period for Biologics

February 02, 2015

The 2016 White House Budget proposes a change to the data exclusivity period for biologics and the authority to influence drug pricing.

Preventing Tablet Tooling Problems

February 02, 2015

Tooling can be damaged by poor handling or problems in process design or material choice.